IBDEI0JZ ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8989,1,4,0)
 ;;=4^K71.3
 ;;^UTILITY(U,$J,358.3,8989,2)
 ;;=^5008797
 ;;^UTILITY(U,$J,358.3,8990,0)
 ;;=K71.4^^39^404^29
 ;;^UTILITY(U,$J,358.3,8990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8990,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Lobular Hepatitis
 ;;^UTILITY(U,$J,358.3,8990,1,4,0)
 ;;=4^K71.4
 ;;^UTILITY(U,$J,358.3,8990,2)
 ;;=^5008798
 ;;^UTILITY(U,$J,358.3,8991,0)
 ;;=K75.81^^39^404^21
 ;;^UTILITY(U,$J,358.3,8991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8991,1,3,0)
 ;;=3^Nonalcoholic Steatohepatitis (NASH)
 ;;^UTILITY(U,$J,358.3,8991,1,4,0)
 ;;=4^K75.81
 ;;^UTILITY(U,$J,358.3,8991,2)
 ;;=^5008828
 ;;^UTILITY(U,$J,358.3,8992,0)
 ;;=K75.89^^39^404^18
 ;;^UTILITY(U,$J,358.3,8992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8992,1,3,0)
 ;;=3^Inflammatory Liver Disease,Oth Spec
 ;;^UTILITY(U,$J,358.3,8992,1,4,0)
 ;;=4^K75.89
 ;;^UTILITY(U,$J,358.3,8992,2)
 ;;=^5008829
 ;;^UTILITY(U,$J,358.3,8993,0)
 ;;=K76.4^^39^404^23
 ;;^UTILITY(U,$J,358.3,8993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8993,1,3,0)
 ;;=3^Peliosis Hepatis
 ;;^UTILITY(U,$J,358.3,8993,1,4,0)
 ;;=4^K76.4
 ;;^UTILITY(U,$J,358.3,8993,2)
 ;;=^91041
 ;;^UTILITY(U,$J,358.3,8994,0)
 ;;=K71.50^^39^404^27
 ;;^UTILITY(U,$J,358.3,8994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8994,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Active Hepatitis w/o Ascites
 ;;^UTILITY(U,$J,358.3,8994,1,4,0)
 ;;=4^K71.50
 ;;^UTILITY(U,$J,358.3,8994,2)
 ;;=^5008799
 ;;^UTILITY(U,$J,358.3,8995,0)
 ;;=K71.51^^39^404^28
 ;;^UTILITY(U,$J,358.3,8995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8995,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Active Hepatitis w/ Ascites
 ;;^UTILITY(U,$J,358.3,8995,1,4,0)
 ;;=4^K71.51
 ;;^UTILITY(U,$J,358.3,8995,2)
 ;;=^5008800
 ;;^UTILITY(U,$J,358.3,8996,0)
 ;;=K71.7^^39^404^31
 ;;^UTILITY(U,$J,358.3,8996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8996,1,3,0)
 ;;=3^Toxic Liver Disease w/ Fibrosis & Cirrhosis of Liver
 ;;^UTILITY(U,$J,358.3,8996,1,4,0)
 ;;=4^K71.7
 ;;^UTILITY(U,$J,358.3,8996,2)
 ;;=^5008802
 ;;^UTILITY(U,$J,358.3,8997,0)
 ;;=K71.8^^39^404^35
 ;;^UTILITY(U,$J,358.3,8997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8997,1,3,0)
 ;;=3^Toxic Liver Disease w/ Oth Disorders of Liver
 ;;^UTILITY(U,$J,358.3,8997,1,4,0)
 ;;=4^K71.8
 ;;^UTILITY(U,$J,358.3,8997,2)
 ;;=^5008803
 ;;^UTILITY(U,$J,358.3,8998,0)
 ;;=K71.9^^39^404^36
 ;;^UTILITY(U,$J,358.3,8998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8998,1,3,0)
 ;;=3^Toxic Liver Disease,Unspec
 ;;^UTILITY(U,$J,358.3,8998,1,4,0)
 ;;=4^K71.9
 ;;^UTILITY(U,$J,358.3,8998,2)
 ;;=^5008804
 ;;^UTILITY(U,$J,358.3,8999,0)
 ;;=K75.2^^39^404^22
 ;;^UTILITY(U,$J,358.3,8999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8999,1,3,0)
 ;;=3^Nonspecific Reactive Hepatitis
 ;;^UTILITY(U,$J,358.3,8999,1,4,0)
 ;;=4^K75.2
 ;;^UTILITY(U,$J,358.3,8999,2)
 ;;=^5008826
 ;;^UTILITY(U,$J,358.3,9000,0)
 ;;=K75.3^^39^404^13
 ;;^UTILITY(U,$J,358.3,9000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9000,1,3,0)
 ;;=3^Granulomatous Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,9000,1,4,0)
 ;;=4^K75.3
 ;;^UTILITY(U,$J,358.3,9000,2)
 ;;=^5008827
 ;;^UTILITY(U,$J,358.3,9001,0)
 ;;=K76.6^^39^404^24
 ;;^UTILITY(U,$J,358.3,9001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9001,1,3,0)
 ;;=3^Portal Hypertension
 ;;^UTILITY(U,$J,358.3,9001,1,4,0)
 ;;=4^K76.6
 ;;^UTILITY(U,$J,358.3,9001,2)
 ;;=^5008834
